Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$7.76M$7.76Mderived+6.1% vs Q4 2021 Net Income$837.82K$837.82KderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$405,360N/M Operating Cash Flowderived$2,429,736+45.7% Free Cash Flowderived$2,454,747+76.9% Margins · derivedOperating margin5.2%+16.3 pt vs Q4 2021
Net margin10.8%+19.5 pt vs Q4 2021
ended Nov 30, 2022 · filed Feb 28, 2023 · 90 d after period end